Perrigo (PRGO) Reaffirms 2026 Guidance, Is The Three S Plan Priced In?
Perrigo (PRGO) grabbed investor attention after reaffirming its 2026 guidance and highlighting progress on its Three-S plan. The plan focuses on portfolio streamlining and debt reduction, alongside expectations of a stronger second half.
Perrigo’s reaffirmed 2026 guidance comes after a sharp 53.43% 90-day share price return and a 13.72% 7-day move. However, the 1-year total shareholder return is still down 21.33% and the 5-year total shareholder return has declined 60%, so recent momentum contrasts with a tough longer-term record.
Compare Perrigo’s rebound with a curated 32 high quality undervalued stocks that also pair improving sentiment with what our models flag as solid quality and potential mispricing.
Perrigo’s sharp rebound sits between two stories. Either the Three-S execution and guidance are finally showing through in the numbers, or short term sentiment has simply swung too far. It is time to test what the valuation implies.
Most Popular Narrative: 6.5% Undervalued
The most followed valuation work on Perrigo pegs fair value at $16.50, a touch above the latest $15.42 close. This puts the recent rally into a tighter context for anyone weighing the Three-S story against current pricing.
The aging global population and rising consumer interest in self-care and wellness continue to create longer-term demand tailwinds for Perrigo's OTC and nutrition products, providing stable, defensive revenue streams even in periods of macro uncertainty.
See why 13 investors see Perrigo as 7% undervalued.
Result: Fair Value of $16.50 (UNDERVALUED)
Still, Perrigo’s dependence on store-brand products with limited pricing power and its recent goodwill impairment charges introduce real pressure points that could quickly challenge the upbeat valuation story.
Find out about the key risks to this Perrigo narrative.
Next Steps
Perrigo’s story mixes optimism and caution, which means the real question is where you land on that spectrum once you review the full picture yourself. To weigh both sides with the same data set investors are using, start with the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Perrigo?
If Perrigo has sharpened your focus on valuation and quality, do not stop here. Broader opportunity often emerges where fewer investors are already looking.
Use the Simply Wall Street Screener to quickly surface opportunities that fit your own risk, income, and quality preferences.
- Target reliable cash generators by checking companies with resilient finances through the list of solid balance sheet and fundamentals (24 results).
- Hunt for mispriced quality by scanning the 32 high quality undervalued stocks that pairs financial strength with what our models flag as potential upside.
- Spot early-stage potential by reviewing the 16 high quality undiscovered gems that combine strong fundamentals with lower current market attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com